Published On: December 12, 2022Categories: Podcast

Dr Heike Röckmann, head of the drug survivability of omalizumab in chronic urticaria (DruSO-CU) project joins Professor Marcus Maurer to discuss the global project, the difficulties which were encountered, and how the UCARE network helped overcome these challenges. The focus of this podcast is on the importance of identifying the data in this important project.

Read more news regarding urticaria

  • New centers,News

    March 15, 2024

    A very warm welcome to our newest UCARE Center in Germany: Universitätsklinikum Hamburg-Eppendorf (UKE)Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP) Head: Prof. Dr. Matthias Augustin Deputy: Prof. [...]

  • Journal Club

    March 15, 2024

    Join us on Thursday, March 21 from 12.00 to 12.45 pm CET, for the UCARE LevelUP Journal Club! JORGE SÁNCHEZ Prof, MD, MSc, EAC, PhD  (Medellin, Colombia) will speak on “Prospective analysis of the [...]

  • New centers,News

    March 12, 2024

    A very warm welcome to our newest UCARE Center in Kazakhstan: Kazakhstan, AstanaHospital of the Medical Center Presidential Administration Republic of Kazakhstan Allergy CenterHead: Dr. Tussupbekova Galiya MarksovnaAuditor: Prof. Zhanat [...]